Skip to Main Content

Author Details

Arun P Wiita
University of California San Francisco
2002
64
27
PMIDPaper TitleJournal TitlePublished Year
36846905Cytomegalovirus seropositivity is associated with improved responses to CD38 monoclonal antibody therapies in multiple myeloma: A single-centre retrospective study.Br J Haematol2023
37904942Tumor-wide RNA splicing aberrations generate immunogenic public neoantigens.bioRxiv2023
37904046Structural surfaceomics reveals an AML-specific conformation of integrin β<sub>2</sub> as a CAR T cellular therapy target.Nat Cancer2023
37696959Transcriptional repression upon S phase entry protects genome integrity in pluripotent cells.Nat Struct Mol Biol2023
37961484Challenges in the discovery of tumor-specific alternative splicing-derived cell-surface antigens in glioma.bioRxiv2023
37344251Overcoming proteasome inhibitor resistance in the immunotherapy era.Trends Pharmacol Sci2023
36993417SLAPSHOT reveals rapid dynamics of extracellularly exposed proteome in response to calcium-activated plasma membrane phospholipid scrambling.bioRxiv2023
37169815A CRISPR-engineered isogenic model of the 22q11.2 A-B syndromic deletion.Sci Rep2023
37036222"Cell Surface Capture" Workflow for Label-Free Quantification of the Cell Surface Proteome.J Vis Exp2023
36846905Cytomegalovirus seropositivity is associated with improved responses to CD38 monoclonal antibody therapies in multiple myeloma: A single-centre retrospective study.Br J Haematol2023
37961484Challenges in the discovery of tumor-specific alternative splicing-derived cell-surface antigens in glioma.bioRxiv2023
37904942Tumor-wide RNA splicing aberrations generate immunogenic public neoantigens.bioRxiv2023
37904046Structural surfaceomics reveals an AML-specific conformation of integrin β<sub>2</sub> as a CAR T cellular therapy target.Nat Cancer2023
37696959Transcriptional repression upon S phase entry protects genome integrity in pluripotent cells.Nat Struct Mol Biol2023
36993417SLAPSHOT reveals rapid dynamics of extracellularly exposed proteome in response to calcium-activated plasma membrane phospholipid scrambling.bioRxiv2023
37344251Overcoming proteasome inhibitor resistance in the immunotherapy era.Trends Pharmacol Sci2023
37169815A CRISPR-engineered isogenic model of the 22q11.2 A-B syndromic deletion.Sci Rep2023
37036222"Cell Surface Capture" Workflow for Label-Free Quantification of the Cell Surface Proteome.J Vis Exp2023
35880301ECM dimensionality tunes actin tension to modulate endoplasmic reticulum function and spheroid phenotypes of mammary epithelial cells.EMBO J2022
36311892Unraveling the surface proteomic profile of multiple myeloma to reveal new immunotherapeutic targets and markers of drug resistance.Cell Stress2022
35840578The surfaceome of multiple myeloma cells suggests potential immunotherapeutic strategies and protein markers of drug resistance.Nat Commun2022
36170375Therapeutic implications of mitochondrial stress-induced proteasome inhibitor resistance in multiple myeloma.Sci Adv2022
35446347Secretory autophagy maintains proteostasis upon lysosome inhibition.J Cell Biol2022
35880301ECM dimensionality tunes actin tension to modulate endoplasmic reticulum function and spheroid phenotypes of mammary epithelial cells.EMBO J2022
35853457Allosteric HSP70 inhibitors perturb mitochondrial proteostasis and overcome proteasome inhibitor resistance in multiple myeloma.Cell Chem Biol2022
35840578The surfaceome of multiple myeloma cells suggests potential immunotherapeutic strategies and protein markers of drug resistance.Nat Commun2022
35853457Allosteric HSP70 inhibitors perturb mitochondrial proteostasis and overcome proteasome inhibitor resistance in multiple myeloma.Cell Chem Biol2022
35446347Secretory autophagy maintains proteostasis upon lysosome inhibition.J Cell Biol2022
36311892Unraveling the surface proteomic profile of multiple myeloma to reveal new immunotherapeutic targets and markers of drug resistance.Cell Stress2022
36170375Therapeutic implications of mitochondrial stress-induced proteasome inhibitor resistance in multiple myeloma.Sci Adv2022
32702189Variants of uncertain significance in prenatal microarrays: a retrospective cohort study.BJOG2021
33727310Surface Proteomics Reveals CD72 as a Target for <i>In Vitro</i>-Evolved Nanobody-Based CAR-T Cells in <i>KMT2A/MLL1</i>-Rearranged B-ALL.Cancer Discov2021
33712811Author Correction: IFITM3 functions as a PIP3 scaffold to amplify PI3K signalling in B cells.Nature2021
34357379FcεRIγ-negative NK cells persist in vivo and enhance efficacy of therapeutic monoclonal antibodies in multiple myeloma.Blood Adv2021
32702189Variants of uncertain significance in prenatal microarrays: a retrospective cohort study.BJOG2021
34533192GRASP55 restricts early-stage autophagy and regulates spatial organization of the early secretory network.Biol Open2021
33712811Author Correction: IFITM3 functions as a PIP3 scaffold to amplify PI3K signalling in B cells.Nature2021
33727310Surface Proteomics Reveals CD72 as a Target for <i>In Vitro</i>-Evolved Nanobody-Based CAR-T Cells in <i>KMT2A/MLL1</i>-Rearranged B-ALL.Cancer Discov2021
34533192GRASP55 restricts early-stage autophagy and regulates spatial organization of the early secretory network.Biol Open2021
34357379FcεRIγ-negative NK cells persist in vivo and enhance efficacy of therapeutic monoclonal antibodies in multiple myeloma.Blood Adv2021
31595037DNA methyltransferase inhibitors upregulate CD38 protein expression and enhance daratumumab efficacy in multiple myeloma.Leukemia2020
31595037DNA methyltransferase inhibitors upregulate CD38 protein expression and enhance daratumumab efficacy in multiple myeloma.Leukemia2020
32132707Mitochondrial stress is relayed to the cytosol by an OMA1-DELE1-HRI pathway.Nature2020
32123307Evaluating the efficacy of multiple myeloma cell lines as models for patient tumors via transcriptomic correlation analysis.Leukemia2020
32297217Lessons Learned from Proteasome Inhibitors, the Paradigm for Targeting Protein Homeostasis in Cancer.Adv Exp Med Biol2020
31932738The LC3-conjugation machinery specifies the loading of RNA-binding proteins into extracellular vesicles.Nat Cell Biol2020
32205485Prevalence of Partial Hydatidiform Mole in Products of Conception From Gestations With Fetal Triploidy Merits Reflex Genotype Testing Independent of the Morphologic Appearance of the Chorionic Villi.Am J Surg Pathol2020
32766586Engineered ACE2 receptor traps potently neutralize SARS-CoV-2.bioRxiv2020
33149299IFITM3 functions as a PIP3 scaffold to amplify PI3K signalling in B cells.Nature2020
33093202Engineered ACE2 receptor traps potently neutralize SARS-CoV-2.Proc Natl Acad Sci U S A2020
  • 1 - 50 of 128

Recommended Authors

Alexandre R Campos
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 2019
Number of shared co-authors 0
Andrew Macklin
Margaret Cancer Center
Career Start Year 2016
Number of shared co-authors 0
Giulia Biancon
Yale School of Medicine
Career Start Year 2016
Number of shared co-authors 0
Jihye Park
Dana-Farber Cancer Institute, Harvard Medical School
Career Start Year 2015
Number of shared co-authors 1
Alexandre Rosa Campos
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 2015
Number of shared co-authors 0
Fabian Coscia
Max-Delbruck-Center for Molecular Medicine in the Helmholtz Association (MDC)
Career Start Year 2011
Number of shared co-authors 0
Vladimir Ignatchenko
Margaret Cancer Center
Career Start Year 2009
Number of shared co-authors 0
Yansheng Liu
Yale University School of Medicine
Career Start Year 2008
Number of shared co-authors 11
Javier A Alfaro
International Centre for Cancer Vaccine Science, University of Gdansk
Career Start Year 2008
Number of shared co-authors 0
Eric Paquet
University of Laval
Career Start Year 2007
Number of shared co-authors 0
Andrew T Magis
Institute for Systems Biology
Career Start Year 2007
Number of shared co-authors 1
John R Mills
Mayo Clinic
Career Start Year 2007
Number of shared co-authors 0
Henrik J Johansson
Karolinska Institutet
Career Start Year 2005
Number of shared co-authors 0
Abdullah Kahraman
University of Zurich
Career Start Year 2005
Number of shared co-authors 3
Andrew V Kossenkov
The Wistar Institute
Career Start Year 2003
Number of shared co-authors 0
Olivier Elemento
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 2
Tamar Geiger
Tel Aviv University
Career Start Year 2000
Number of shared co-authors 2
Yan W Asmann
Mayo Clinic
Career Start Year 2000
Number of shared co-authors 2
Jayantha Gunaratne
Institute of Molecular and Cell Biology
Career Start Year 2000
Number of shared co-authors 1
Parag Mallick
Stanford University
Career Start Year 2000
Number of shared co-authors 10
Chenwei Lin
Clinical Research Division, Fred Hutchinson Cancer Center
Career Start Year 2000
Number of shared co-authors 6
Xingzhi Song
The University of Texas MD Anderson Cancer Center
Career Start Year 1998
Number of shared co-authors 1
Alex Kentsis
Memorial Sloan-Kettering Cancer Center
Career Start Year 1998
Number of shared co-authors 1
Thomas Kislinger
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 1997
Number of shared co-authors 2
Janne Lehti??
Karolinska Institutet
Career Start Year 1997
Number of shared co-authors 0
Damarys Loew
Institut Curie, PSL Research University
Career Start Year 1996
Number of shared co-authors 0
Peter Kuhn
University of Tubingen
Career Start Year 1994
Number of shared co-authors 3
David Feny??
Institute for Systems Genetics, NYU Grossman School of Medicine
Career Start Year 1989
Number of shared co-authors 6
Todd R Golub
Broad Institute of MIT and Harvard
Career Start Year 1989
Number of shared co-authors 3
Garry P Nolan
Stanford University School of Medicine
Career Start Year 1985
Number of shared co-authors 5

Collaborators

Yu-Hsiu Lin
University of California san francisco
Co-authored papers 10
James A Wells
Department of Pharmaceutical Chemistry, University of California San Francisco
Co-authored papers 7
Ian D Ferguson
Yale University School of Medicine
Co-authored papers 6
Christoph Driessen
Cantonal Hospital St. Gallen
Co-authored papers 4
Margarette C Mariano
Albert Einstein College of Medicine
Co-authored papers 4
Lily Yeh Jan
Co-authored papers 3
David M Weinstock
Merck & Co.
Co-authored papers 3
Jayanta Debnath
University of California San Francisco
Co-authored papers 3
Michael S Diamond
Washington University School of Medicine
Co-authored papers 2
Tanja Kortemme
University of California san francisco
Co-authored papers 2
Martin Kampmann
Institute for Neurodegenerative Diseases, University of California san francisco
Co-authored papers 2
Alma L Burlingame
Department of Pharmaceutical Chemistry, University of California san francisco
Co-authored papers 2
FuiBoon Kai
University of California San Francisco
Co-authored papers 2
Benjamin G Barwick
Emory University School of Medicine
Co-authored papers 2
Eric J Huang
University of California san francisco
Co-authored papers 2
Jordan Ye
University of California San Francisco
Co-authored papers 2
Oren S Rosenberg
University of California san francisco
Co-authored papers 2
Irene Lui
Department of Pharmaceutical Chemistry, University of California san francisco
Co-authored papers 2
Jack Taunton
University of California san francisco
Co-authored papers 2
Robert L Moritz
Institute for Systems Biology
Co-authored papers 2
Lawrence H Boise
Winship Cancer Institute, Emory University
Co-authored papers 2
Arie Perry
University of California san francisco
Co-authored papers 1
Mercedes F Paredes
University of California san francisco
Co-authored papers 1
Joanna J Phillips
University of California san francisco
Co-authored papers 1
Lukas Reiter
Co-authored papers 1
Steve Miller
University of CaliforniaSan Francisco
Co-authored papers 1
R Dyche Mullins
University of California San Francisco, USA Howard Hughes Medical Institute
Co-authored papers 1
Scott R VandenBerg
University of California san francisco
Co-authored papers 1
Steven A Carr
Broad Institute of MIT and Harvard
Co-authored papers 1
Ruth H??ttenhain
Quantitative Biosciences Institute (QBI), University of California san francisco
Co-authored papers 1
Release 1.2